Injections Start for First Japan-made COVID Vaccine, Targeting XBB 1.5 Variant
![](https://japannews.yomiuri.co.jp/wp-content/uploads/2023/12/vaccine-1214.jpg)
A doctor administers a Daiichi Sankyo Co. vaccine to a patient at a hospital in Itabashi Ward, Tokyo, on Wednesday.
12:40 JST, December 14, 2023
TOKYO — Shots of the first Japan-made vaccine for the novel coronavirus are finally being administered, nearly four years after the start of the pandemic.
The vaccine, developed by Daiichi Sankyo Co. and targeting the omicron XBB 1.5 variant, uses messenger RNA like the shots made by Pfizer Inc. and Moderna Inc. in the United States, which are also widely used in Japan.
Production and sale of the vaccine for the virus’ original strain was approved by the Health, Labor and Welfare Ministry in August. In September, the XBB variant shot was also approved, and the health ministry contracted with Daiichi Sankyo to purchase 1.4 million doses. The doses will be used for booster shots for those age 12 and older.
"Society" POPULAR ARTICLE
-
Japan Court OKs Sex Change without Surgery
-
3 Climbers Die On Mt. Fuji Within 2 Days Of Opening; Japan Police, Guides Urge Climbers To Prepare Well, Make Wise Decisions
-
Sex Crime Perpetrators Linked to U.S. Military in 166 Cases in Japan over 35 years; Local, Prefectural Governments Often Not Aware of Crimes
-
New Mt. Fuji Rules Reduce ‘Bullet Climbers’ by 90%; Access to Japan’s Iconic Peak Limited from Yamanashi Pref. Side
-
Tokaido Shinkansen Trains Suspended Between Hamamatsu and Nagoya Due to Accident; Resuming Services Expected Noon at Earliest
JN ACCESS RANKING